A major goal of this SPORE and, more specifically, this program is to identify and fund projects that will leadto clinically testable hypotheses aimed at reducing the incidence and mortality rate of head and neck canceror improving the quality of life of patients with head and neck cancers. The DRP has continued to supportnew, novel research in head and neck cancer, with 12 DRP awards made to talented investigators (MitchellFrederick, Ph.D., Ann Marie Gillenwater, M.D., Michael Story, Ph.D., Ho-Young Lee, Ph.D., Julie Izzo, M.D.,Vassiliki A. Papadimitrakopoulou, M.D., Mahitosh Mandel, Ph.D., K.S. Clifford Chao, M.D., Pulivarthi Rao,Ph.D., Gianpietro Dotti, M.D., Nadarajah Vigneswaran, D.M.D., and Waldemar Priebe, Ph.D., over the past 4years. In addition, 12 DRP proposals were submitted in response to the Fall 2006 solicitation, which wererecently reviewed and, with input of our Internal Advisors and Executive Committee, will allow funding ofthree additional awards to Faye M. Johnson, M.D., Ph.D., Ja Seok Koo, Ph.D., in early 2007, and asubsequent award to an investigator from Rice University, Rebecca Kortum-Richards, Ph.D. The specificobjectives of the Developmental Research Program are to:1. Solicit pilot projects in head and neck cancer translational research that have significant potential forreducing the incidence and mortality rate of head and neck cancer and/or improving the quality of life ofpatients with head and neck cancers.2. Foster collaborative efforts among SPORE investigators and with other investigators to encourage thedevelopment of new and innovative ideas and approaches.3. Encourage and assist young investigators with promising preliminary data developed with support of thisProgram to apply for extramural peer-reviewed funding.4. When necessary or possible, promote the most promising projects in the Developmental ResearchProgram to full SPORE research projects.The projects funded through the Developmental Research Program are diverse but share common themesrelated to their translational potential in head and neck cancers. In response to our previous review, we haverevised and clarified the process by which applications are solicited from qualified candidates, and haveinitiated a new collaboration, based on an institutional U54 grant ('Partnership for Excellence'), with thePuerto Rico Cancer Center at the University of Puerto Rico to enhance our outreach in soliciting noveldevelopmental projects from qualified candidates, particularly women and minority investigators. We believethese and other changes to our application will significantly strengthen this program over the next grantcycle.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
2P50CA097007-06A1
Application #
7510717
Study Section
Special Emphasis Panel (ZCA1-GRB-I (M1))
Project Start
2008-08-01
Project End
2013-07-31
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
6
Fiscal Year
2008
Total Cost
$92,000
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Yin, Guosheng; Chen, Nan; Lee, J Jack (2018) Bayesian Adaptive Randomization and Trial Monitoring with Predictive Probability for Time-to-event Endpoint. Stat Biosci 10:420-438
Antczak, Nicole M; Walker, Alice R; Stern, Hannah R et al. (2018) Characterization of Nine Cancer-Associated Variants in Human DNA Polymerase ?. Chem Res Toxicol 31:697-711
MD Anderson Head and Neck Cancer Symptom Working Group; Kamal, Mona; Rosenthal, David I et al. (2018) Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors. Radiother Oncol 126:75-80
Joint Head and Neck Radiotherapy-MRI Development Cooperative (2018) Dynamic contrast-enhanced magnetic resonance imaging for head and neck cancers. Sci Data 5:180008
Zhang, Hua; Sturgis, Erich; Zhu, Lijun et al. (2018) The Modifying Effect of a Functional Variant at the miRNA Binding Site in E2F1 Gene on Recurrence of Oropharyngeal Cancer Patients with Definitive Radiotherapy. Transl Oncol 11:633-638
Gleber-Netto, Frederico O; Zhao, Mei; Trivedi, Sanchit et al. (2018) Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma. Cancer 124:84-94
(2018) Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet 50:668-681
Jurkovic, Ines-Ana; Kocak-Uzel, Esengul; Mohamed, Abdallah Sherif Radwan et al. (2018) Dosimetric and Radiobiological Evaluation of Patient Setup Accuracy in Head-and-neck Radiotherapy Using Daily Computed Tomography-on-rails-based Corrections. J Med Phys 43:28-40
Huckins, L M; Hatzikotoulas, K; Southam, L et al. (2018) Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa. Mol Psychiatry 23:1169-1180
M. D. Anderson Cancer Center Head and Neck Quantitative Imaging Working Group (2018) Investigation of radiomic signatures for local recurrence using primary tumor texture analysis in oropharyngeal head and neck cancer patients. Sci Rep 8:1524

Showing the most recent 10 out of 370 publications